It has been a while since we have looked at the role of defensive medicine, or testing and procedures generated from fear of malpractice suits, in health spending. A Research Letter published in the Journal of the American Medical Association looked at the relationship between defensive medicine and the use of three hospital services. (JAMA Int. Med. Article) Thirty-nine hospitalists were involved in the study and were asked to rate their own level of defensiveness in regard to orders they actually placed in the treatment of patients. Defensiveness was rated on a scale from zero to four and the costs of the various orders was collected. An order not at all spurred by malpractice concerns was rated zero and various levels of defensiveness were represented from 1 to 4, with 4 being a completely defensive order. The relationship between use of defensive orders and a doctor’s attitude toward malpractice was also examined. Four physicians said they had no defensive orders and 21 had at least one order they said was largely defensive. Twenty-eight percent of all orders were defensive to some degree. Physicians with more defensive orders did not have significantly more total orders or significantly more overall cost per patient than did doctors with fewer defensive orders. About 13% of total patient costs were identified as due to defensive orders. Orders which were solely due to malpractice concerns were about 2.9% of costs, primarily via additional hospital days. While the authors refer to this as a small amount of cost, even the roughly 3% number would be billions of dollars in savings a year. Fear of malpractice is a real concern, both because of probably unnecessary utilization and cost it engenders, but also because it provides cover for physicians who may want to deliver more services for economic reasons.
✅ Subscribe via Email
About this Blog
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at khroche@healthy-skeptic.com.
Healthy Skeptic Podcast
Research
MedPAC 2019 Report to Congress
June 18, 2019
Headlines
Tags
Access
ACO
Care Management
Chronic Disease
Comparative Effectiveness
Consumer Directed Health
Consumers
Devices
Disease Management
Drugs
EHRs
Elder Care
End-of-Life Care
FDA
Financings
Genomics
Government
Health Care Costs
Health Care Quality
Health Care Reform
Health Insurance
Health Insurance Exchange
HIT
HomeCare
Hospital
Hospital Readmissions
Legislation
M&A
Malpractice
Meaningful Use
Medicaid
Medical Care
Medicare
Medicare Advantage
Mobile
Pay For Performance
Pharmaceutical
Physicians
Providers
Regulation
Repealing Reform
Telehealth
Telemedicine
Wellness and Prevention
Workplace
Related Posts
Commentary
The Latest Inflation Reading
October 11, 2024
The Latest Inflation Reading
Inflation continues to be present, particularly in items consumers have to buy--food, housing, clothes, medical…
Commentary
Drug Overdoses in Minnesota
October 10, 2024
Drug Overdoses in Minnesota
Drug overdose deaths may be down in Minnesota, but total overdoses rose, as nothing is…
Commentary
Another Day, Another Mediocre Debt Auction
October 10, 2024
Another Day, Another Mediocre Debt Auction
Another mediocre US debt sale confirms that the Federal Reserve doesn't control rates in that…